The report provides an overview of the “3D Bioprinting Market” industry including definitions, division, key vendors, key Development and market challenges. The 3D Bioprinting Market analysis is provided the international markets including development trends, competitive landscape analysis, and key regions development status
Through the statistical analysis, the report depicts the global 3D Bioprinting Market including capacity, production, production value, cost/profit, supply/demand and import/export. The entire market is further distributed by company, by country, and by application/type for the competitive landscape analysis.
Get a Sample Copy of the Report at – https://www.absolutereports.com/enquiry/request-sample/13999778
The Global 3D Bioprinting Market was valued at USD 385.56 million in 2018 and is expected to register a CAGR of 25.36% during the forecast period (2019-2024). The global 3D bioprinting market is expected to grow, owing to its revolutionary breakthrough in healthcare and pharmaceutical industries. The increasing technological advancements, government intervention for improving healthcare, and increasing investments in R&D are also significant factors driving the studied market growth.
The primarily growing bioprinting applications include 3D bioprinted tissue and hair follicles, as they are very beneficial to cosmetics companies, especially in Europe, where animal testing for cosmetics was banned in 2013. For a cosmetic company, the advantage will be the ability to economically and ethically test products (i.e., not on animals) across varying skin types, for more accurate results.
Growing government support is also attracting many investors to invest in R&D programs, which is expected to develop space for the studied market. In 2018, Mapp Biopharmaceutical Inc. announced that it had been awarded a contract of USD14.8 million, with options for an additional USD 32.0 million, by the Biomedical Advanced Research and Development Authority (BARDA).
Further, a significant increase in the number of older adults is projected in the coming decades, which is expected to drive the need for 3D bioprinting reflecting the growth of the market.
Scope of the Report
3D bioprinting is an emerging field represented by various biologically applied deposition and assembling systems, which include direct writing, photolithography, microstamping, extrusion, laser writing, stereolithography, electro-printing, microfluidics, and inkjet deposition.
The 3D Bioprinting Market report also presents the vendor countryside and a corresponding detailed analysis of the major vendors operating in the market. 3D Bioprinting Market report analyses the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios.
Key Market Trends
Drug Testing to Hold Major Share
3D bioprinters are of the highest importance for drug testing and clinical trials applications expected to drastically reduce the need for animal trials (therefore not only being ethically beneficial but also being cost-effective).
Traditionally, clinical trials for new drug development involved testing on animals with artificially induced affected tissues. With the advent of 3D bioprinting, drug developers will be able to address the complications associated with human clinical trials of new drugs, by identifying them in a short period (since these can be tested with human-like 3D printed tissues).
Thus, they are expected to reduce the losses incurred during late-stage failures. The regulatory agency of the United States Food and Drug Administration has already started to consider integrating alternatives for drug safety and efficacy assessment, providing scope for the market. Companies like Organovo (US based) were instrumental in the development of 3D bioprinter able to develop liver and kidney tissue for drug discovery applications.
Cosmetic companies are also potential buyers of the bioprinter technology. In 2013, the European Union prohibited the use of cosmetics developed by animal testing. Prohibition of retailing products tested abroad on animals was also levied. Such regulations have accelerated the use of alternatives like bioprinting.
Asia-Pacific Anticipated to Witness Fastest Growth
Asia-Pacific is the fastest growing market for 3D bioprinting, mainly due to a strong existing consumer base that will drive demand for 3D bioprinting, huge scope of 3D printing in medical services, increasing R&D for 3D printing, and government support and tax incentives. The growing number of cancer cases and the increasing the number of cancer treatments in the region are also expected to fuel the adoption of 3D bioprinting technology. According to the World Cancer Research Fund, the cancer rate is the highest in Australia and New Zealand in the world.
Enquire Before Purchasing this Report – https://www.absolutereports.com/enquiry/pre-order-enquiry/13999778
Reasons to Purchase this Report
- Analyzing various perspectives of the market with the help of Porter’s five forces analysis
- Study on product type and application expected to dominate the market.
- Study on regions expected to witness fastest growth during the forecast period.
- Identify the latest developments, market shares and strategies employed by the major market players.
- 3 months’ analyst support along with the Market Estimate sheet (in excel).
Detailed Table of Content of Global 3D Bioprinting Market – Growth, Trends, Forecast and Challenges (2019 – 2024)
1.1 Study Deliverables
1.2 General Study Assumptions
2. Research Methodology
2.2 Analysis Methodology
2.3 Study Phases
2.4 Econometric Modelling
3. Executive Summary
4. Market Overview and Trends of 3D Bioprinting Market
4.2 Market Trends
4.3 Porter’s Five Force Framework
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Power of Consumers
4.3.3 Threat of New Entrants
4.3.4 Threat of Substitute Products and Services
4.3.5 Competitive Rivalry within the Industry
5. Market Dynamics of 3D Bioprinting Market
5.1.1 Increasing Production
5.1.2 Rising Demand
6. Global 3D Bioprinting Market Segmentation, By Capacity
7. Global 3D Bioprinting Market Segmentation, By Material Type
7.1 Type 1
7.2 Type 2
7.3 Type 3
8. Global 3D Bioprinting Market Segmentation, Segmented by Region
8.1 North America
8.1.1 United States
8.1.3 Rest of North America
8.2.4 Rest of Asia-Pacific
8.3.1 United Kingdom
8.3.5 Rest of Europe
8.4 Rest of the World
8.4.2 South Africa
9. Competitive Landscape and Introduction of 3D Bioprinting Market
9.2 Market Share Analysis
9.3 Developments of Key Players
10. Key Vendor Analysis (Overview, Products & Services, Strategies)
10.1 Company 1
10.2 Company 2
10.3 Company 3
And Many More….
No. of Pages: – 110
Purchase this Report (Price 4250 USD for a single-user license) https://www.absolutereports.com/purchase/13999778
About Absolute Reports:
Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.
Name: Mr. Ajay More
Phone: US +1424 253 0807/ UK +44 203 239 8187
Mail id: [email protected]